In this study, CTNNB1 mutation led to abnormally low expression of some genes, suggesting that ARGs are likely to be regulated by mutations in major tumour suppressors or tumour-promoting genes, and hence, may promote tumour progression. This evidence concerns the gene SERPINA2 and neoplasm.